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Abstract 
3-Amino-4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine (5) was synthesized as starting material and investigated as 
cytotoxic and antitumor agent. Compound 5 reacted with different acid anhydrides to afford the corresponding 
imides and bisimide derivatives 6-12. Imides 6-12 were tested for their in vitro cytotoxicity against four different 
cancer cell lines and structure activity relationship’s (SAR’s) was studied. 
Keywords: 2-Thiomethyl-4,6-diphenyl-3-carbonitrilpyridine, Acid Anhydrides, Cytotoxicity. 
 
1. Introduction 
1H-pyrazolo[3,4-b]pyridines comprise a very interesting class of compounds because of their significant and 
divers biological and pharmacological activities, such as antimalarial (Menezes et al. 2002), antiproliferative 
(Poreba et al. 2002), antimicrobial (Goda et al. 2004), cyclin-dependent kinase-inhibiting (Misra et al. 2003), 
cardiovascular (Stasch et al. 2002), antiviral (Azevedo et al. 2002), and antileishmanial activities (Mello et al. 
2004). 
Pyrazole-fused pyridines and pyrimidines are known to possess a wide range of biological activity. Specifically, 
pyrazolopyridines exhibit antitubercular and anxiolytic effects (Sekikawa et al. 1973). 
In view of the above mentioned findings and as continuation of our effort from our laboratory (Fadda et al. 2013; 
Fadda et al. 2012; Fadda et al. 2013; Fadda et al. 2012; Fadda et al. 2013; Fadda et al. 2012; Fadda 2012; Fadda 
& El-Mekawy 2012; Fadda et al. 2011) to identify new candidates that may be of value in designing new potent, 
selective and less toxic antimicrobial agents, we report herein the synthesis of some new heterocycles 
incorporated pyrazolopyridine moiety starting from 3-Amino-4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine (5) in 
order to investigate their antimicrobial activity. It has been reported that pyrroles are important analgesic and 
anti-inflammatory agents (Otmar et al. 2004). In view of these facts, and in continuation of our interest in the 
chemistry of N-phthalimide (Fadda et al. 1999), we undertook the synthesis and cytotoxicity effects against 
different carcinoma cells of some new isoindolin-1,3-dione (N-phthalimides) containing pyrazolopyridine moiety. 
Hence, it was thought that the molecules containing both pyrazolopyridine and phthalimide moieties would have 
a more pronounced biological activity. With this in mind and with ingoing efforts in our laboratory, this paper 
reports a variety of synthetic routes leading to the synthesis of some novel pyrazolopyridine-isoindolin-1,3-dione 
analogues bearing different functional groups, some of which resemble that 5-fluorouracil (5-Fu). Novel 
analogues were evaluated in vitro against HepG2 (human heptacellular liver carcinoma cell lines), WI-38 (skin 
carcinoma cell lines), VERO (cell line was initiated from the kidney of a normal adult African green monkey) 
and MCF-7 (breast cancer cell lines). 
 
2. Results and discussion 
2.1. Chemistry 
In view of these observations and in continuation of previous work in phthalimide chemistry (Fadda et al. 2012), 
we synthesized some new heterocyclic compounds containing N-phthalimide and tested their biological activities. 
The synthetic procedures adopted to obtain the target compounds are depicted in Scheme 1-3. 
The starting material 3-cyano-4,6-diphenyl-2-pyridinethione (3) was prepared in 60% yield by reaction of 
dibenzoylmethane (1) with thiocyanoacetamide (2) under Guareschi-Thorpe reaction condition. 
On the other hand, water at room temperature is an effective medium for simple condensations leading to 
pyrimidine, pyrrole, and pyridine derivatives etc, and such reactions are usually termed “synthesis under 
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physiological (or cell-possible) conditions” (Haley & Maitland 1951). Therefore, dibenzoylmethane (1) and 
thiocyanoacetamide (2) condense together in the presence of aqueous potassium carbonate to yield 3 in 90% 
yield. 
 
 
 
 
 
 
 
Scheme 1. 
 
The IR spectrum of 3 showed the presence of absorption bands at 3150, 2220, and 1300 cm-1 for NH, CN and 
C=S functions, respectively. The mass spectrum of 3 showed the molecular ion peak at m/z 288 (M+) 
corresponding to the molecular formula C18H12N2S. 
Alkylation of pyridinethione derivative 3 was performed by its boiling with methyl iodide in alkaline medium 
resulted in the formation of the S-alkylated product 4. A chemical confirmation of the structure of 4 was obtained 
through the cyclization with hydrazine hydrate, forming the key intermediate 3-amino-4,6-diphenyl-1H-
pyrazolo[3,4-b]pyridine (5). N-alkylation was excluded, since the sole product obtained was the amino 
pyrazolopyridine derivative. 
 
 
 
 
 
 
 
Scheme 2. 
1H-NMR spectrum of the S-methyl derivative 4 showed two singlet signals at δ 2.47 and 8.56 ppm attributable to 
S-methyl and C5-H protons, respectively besides the aromatic protons at δ 7.67-8.30 ppm as multiplet. While 1H-
NMR spectrum of compound 5 showed the disappearance of singlet signal at δ 2.5 ppm and instead appeared 
D2O exchangeable signals at δ 6.51 and 12.8 ppm due to NH2 and NH protons. Moreover, the IR spectrum of 5 
showed absorption bands at 3350 and 3225 cm-1 corresponding to NH2 and NH function groups. 
Moreover, the mass spectrum gave an additional evidence for the structure 5 which showed its molecular ion 
peak at m/z 286 corresponding to a molecular formula C18H14N4. 13C-NMR spectrum showed signals at δ 155 C6-
py, 154 C-NH2, 150 C4-py, 127-136 ppm for aromatic carbons, 91 and 132 for C3 and C4 of pyrazole ring and 
121 C5-pyridine. 
Condensation of the key intermediate 5 with acid anhydrides, namely, phthalic anhydride, 4-nitrophthalic 
anhydride, and 3-nitro phthalic anhydride in refluxing ethanol containing few drops of acetic acid afforded the 
corresponding 2-(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)-isoindolin-1,3-dione derivatives 6-8, 
respectively. The IR spectra of compounds 6-8, in general, showed the absence of absorption frequency of NH2 
function at 3350 cm-1 of compound 5, and instead, the appearance of new band at 1697 cm-1 corresponding to the 
amidic carbonyl function. The mass spectrum of compound 6 showed the molecular ion peak at m/z 416 (M+). 
Similarly, the mass spectra of compounds 7 and 8 showed the molecular ion peaks at m/z 461 (M+) 
corresponding to molecular formula C26H15N5O4. 
Similarly, condensation of 5 with 3,4,5,6-tetrabromophthalic anhydride, and 1,2,4-benzene-tri-carboxylic 
anhydride (trimellitic anhydride) in refluxing ethanol containing few drops of acetic acid afforded the 
corresponding 2-(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)-4,5,6,7-tetrabromoisoindolin-1,3-dione (9) and 
2-(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)isoindolin-1,3-dione-5-carboxylic acid (10). 
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Scheme 3. 
 
Structures 9 and 10 were confirmed by both elemental and spectral analyses. The IR spectra of compound 9 and 
10 showed absorption bands at 3249 and 3234 cm-1corresponding to NH functions, 1739-1695 cm-1 
corresponding to carbonyl groups. The mass spectra of compounds 9 and 10 showed the molecular ion peak at 
m/z 731 (M+) and 460 (M+), respectively. 
In addition, refluxing of compound 5 with pyromellitic anhydride in boiling ethanol containing few drops of 
glacial acetic acid in a molar ratio 1:2 afforded the corresponding pyromellitimide 11. The mass spectrum of 11 
showed the molecular ion peaks at m/z 754 (M+) and 710 (M+-CO2). Moreover, stirring of compound 5 with 
isatoic anhydride in ethanol containing few drops of acetic acid at room temperature afforded the corresponding 
3-(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)-quinazoline-2,4-(1H,3H)dione (12). The IR spectrum of 
compound 12 showed absorption bands at 3250 and 1677 cm-1 corresponding to NH and CO function groups. 
The mass spectroscopic measurement gave an additional evidence for the correct structure of compound 12 
which showed the molecular ion peak at m/z 431 (M+, 100%). 
However, no details reported regarding the synthesis of such compounds in literature. The reaction possibly takes 
place according to one of the following two mechanisms (Fig 1) 
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Fig 1.: Routes for the mechanism of formation of pyrazolopyridine-isoindolin-1,3-dione 6-12 
2.2. Mass spectroscopic studies of isoindolin-1,3-dione (N-phthalimide) compounds 
In recent years, mass spectroscopic studies have been used in various aspects of biochemistry (Garteiz & Walle 
1972; Bosin & Sinnott 1974). 
Nonavialability of the literature on phthalimide derivatives coupled with their use in the field of medicine and 
biochemistry, have promoted us to investigate the fragmentation pathways of some phthalimide derivatives. It 
appears that no report has been made to date on these compounds. In this type of compounds it may be expected 
that the initial charge is localized preferentially on either nitrogen, oxygen, or on aromatic ring. 
The mass spectrum of the pyromellitimide 10, for example, has been investigated. All the compounds 6-12 
yielded easily recognizable molecular ions with characteristic isotopic contribution and weak (M-1) peaks. The 
principle general route of fragmentation peaks of compound 10 is given in Scheme 4. 
In general, the pyromellitimides contains the peaks corresponding to the loss of 44 mass units from the 
molecular ion (M-CO2) (F2). This fragmentation route was supported by corresponding metastable peaks. The 
pyromellitimide contains also an abundant peak due to the elimination of arylnitrile unit. This peak may be 
represented as (Ar-CN) +, the elimination of CO2 and the formation of the latter fragment may be explained in 
terms of Mclafferty rearrangement. A metastable peak at 241.4 verified the genesis of (Ar-CN) + ion from one 
step decomposition of the molecular ion (F2) to give (F7). The subsequent decomposition of arylnitrile ion (F5) 
by the expulsion of CN afforded the substituted pyrazolopyridine ion (F6). Similar elimination of CN and NCS 
from (C6H5-NCS) + has also been observed by Djhrassi et al (Kiahr et al. 1963). Ion F2 readily eliminates either 
mass 44 (-CO2) or arylnitrile fragment to give more stable cation F3 or F7, respectively. This observation is in 
harmony with the results of previous workers (Beynon & Williams 1960). Thus, further fragmentation of F3 by 
loss one or two  
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Scheme 4. General route of fragmentation of pyromellitimide derivative 10 
 
arylnitrile cation afforded an ion F4 or ion at m/e 74, respectively. Cation F7 on further decomposition yields 
cation F4 and F8. 
Other lower fragmentation for the arylnitriles is in accordance with characteristic fragmentation of the 
corresponding hydrocarbons (Beynon et al. 1968). 
In case of compounds 6 and 7 for example, the fragmentation of nitrophthalimide derivatives are unusual and 
distinctive. The ions (P-O) + or (P-OH) +, (P-NO) + and (P-NO2) are almost always of relatively high abundance. 
The molecular ions are usually of high abundance also. The presence of the nitrogen atom is readily apparent by 
the application of the “nitrogen rule”. Even if another substituent group contains a nitrogen atom, the nitro group 
can be quickly recognized by the characteristic fragmentation that is induces and hence the presence of a second 
nitrogen atom can be deduced by inference. 
The molecular ion m/z = 461 loss firstly mass unit of 44 (M+-CO2), followed by loss the heteroaryl cation of 
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mass unit 270 to afford nitrobenzonitrile, of mass 148, which is readily detected. The fragments ions (P-NO) + 
and (P-NO2) + are Permanent. The presence of a benzene ring is indicated by the ions of masses, 51 and 77 and 
also by the meta-stable transition. 
 
 
 
 
This transition parallels the transition in benzene 
 
 
 
 
 
A second meta-stable transition confirms the loss of CO from the (p-NO) + 
 
  
 
 
The nitrobenzenonitrile ion (m/e 148) first of all loss a mass unit 26 or 27 from its molecular ion (148-CN) or 
HCN to give substituted phenyl ion (Ar = nitrobenzene), (m/e = 122, %RA 3.69, %RIC 0.95) 
 
 
  
 
 
 
 
The mass spectra of compounds 6-12 showed a similar fragmentation routes until the formation of the fragment 
F5, which further dissociated by individual routes in each compound according to the type of the heterocyclic 
moiety. 
 
2.3. Pharmacology 
2.3.1. Cytotoxicity 
Cytotoxicity was expressed as the concentration that caused 50% loss of the cell monolayer (IC50). The assay 
was used to examine the newly synthesized compounds. 5-Fluorouracil as a standard anticancer drug was used 
for comparison (Fadda et al. 2012; Fadda et al. 2009). The results of our preliminary screening indicated that 
compounds 8, 9 and 11 showed moderate cytotoxicity activity. The other compounds showed weak cytotoxicity 
activity (Table 1). 
Subsequently, we may conclude the structure activity relationship’s (SAR’s). 1) The presence of basic skeleton 
(phthalimide moiety) is necessary for the broad spectrum of cytotoxic activity towards different cell lines 
(HepG2, WI-38, VERO and MCF-7). 2) Introducing of a nitro group (electron withdrawing group, -ve inductive 
effect) in position 4 of benzene ring in phthalimide moiety increases the activity towards WI-38 and VERO also 
diminishes the activity towards HepG2 and MCF-7 (compound 8). 3) Introducing four bromine atoms (electron 
withdrawing atoms, -ve inductive effect) in benzene ring of phthalimide moiety increases the activity against all 
cell lines (compound 9). 4) According to the above findings the presence of two phthalimide moieties enhanced 
the cytotoxicity activity towards all cell lines (compound 11). 5) In compound 12 the presence of NH group near 
77+ 51++ 26
C6H5+ C6H5+ + C2H2
m.s. 33.8
78+ 52++ 26
+ C2H2C6H6+ C4H4+
m.s. 34.7
93+ 65++ 28
+ COC6H5O+ C5H5+
m.s. 45.4
148+ 121+ + 27
p-NO2-C6H4CN+ p-NO2-C6H3+ +
m.s. 99.9
HCN
148+ 122+ + 26
NO2-C6H4CN+ NO2-C6H4+ +
m.s. 101.5
CN
Chemical and Process Engineering Research                                                                                                                                    www.iiste.org 
ISSN 2224-7467 (Paper) ISSN 2225-0913 (Online) 
Vol.21, 2014 
 
66 
to carbonyl group in isatoic acid moiety act as electron withdrawing group and showed nearly moderate activity 
against HepG2 and WI-38. 6) The presence of electron withdrawing group (NO2 and COOH) in position 5 of 
benzene ring in phthalimide moiety decreases the negative inductive effect on the reaction center of molecule 
and consequently decreases the cytotoxicity activity (compounds 7 and 10). Compound 6 has phthalimide moiety 
with no substituents in benzene ring, showed weak activity. 8) Compound 5 has no phthalimide moiety, showed 
weak cytotoxicity activity. 
Table 1. Cytotoxicity (IC50) of tested compounds on different cell lines 
Compound 
No. 
IC50 (µg/ml)a 
HepG2 WI-38 VERO MCF-7 
5-Fu 8 4 12 18 
5 89 88 76 75 
6 89 92 95 90 
7 83 85 83 78 
8 52 45 48 50 
9 39 41 50 49 
10 60 62 56 58 
11 34 42 50 49 
12 52 51 65 62 
aIC50 (µg/ml): 1-10 (very strong), 11-25 (strong), 26-50 (moderate), 51-100 (weak), 100-200 (very weak), above 
200 (non cytotoxicity). 
5-Flu = 5-Fluorouracil 
Further, in vivo studies are warranted to confirm the biological activity of the newly synthesized 
pyrazolopyridineisoindolin-1,3-dione compounds and to investigate the molecular mechanisms responsible for 
the antitumor activity at the most compounds with a potential pharmaceutical used. 
   
 
 
 
 
 
 
 
Vero cells            WI 38         HEPG-2          MCF-7 
Fig 2.: Confluent Monolayers of cell lines used for testing 
 
3. Conclusion 
In summary, modification of 3-amino-4,6-diphenyl-1H-pyrazolo[3,4-b]pyridine (5) produced compounds with 
potential as anticancer agents. Based on these preliminary screening results, compounds 8, 9 and 11 showed 
significant activity in certain cancer cell and have been targeted for further studies. Compounds 9 and 11 showed 
the highest cytotoxic activity. Meanwhile, compounds 5, 6 and 7 proved to have the weakest activity. 
4. Experimental 
All melting points are recorded on Gallenkamp electric melting point apparatus and are uncorrected. The IR 
spectra v cm-1 (KBr) were recorded on Prerkin Elmer Infrared Spectrophotometer Model 157, Grating. The 13C 
and 1H-NMR spectra were run on Varian Spectrophotometer at 400 MHz and 100 MHz using TMS as an internal 
reference and DMSO-d6 as solvent. The mass spectra (EI) were recorded on 70 ev with Kratos MS equipment 
and/or a Varian MAT 311 A Spectrometer T Cairo Univ., Giza, Egypt, and at Assiut university central lab. 
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Elemental analyses (C, H, and N) were carried out at the Microanalytical Center of Cairo University, Giza, Egypt. 
The results were found to be in good agreement with the calculated values. 
4.1. Synthesis of 3-cyano-4,6-diphenyl-2-pyridine-thione (3) 
It was prepared according to the previously reported method (Haley & Maitland 1951). 
4.2. Synthesis of 4,6-diphenyl-2-methylthiopyridin-3-carbonitrile (4) 
A mixture of 3 (1 mmol) in 10 ml 40% sodium hydroxide was stirred on a water bath at 60°C until the reaction 
mixture became clear. Methyl iodide (1 mmol) was added dropwise to the stirred mixture and the immediately 
formed white precipitate was collected by filtration and crystallized from petroleum ether. Yield (85%); white 
powder; m.p. 120 oC; IR (KBr): ν/cm-1= 2220 (CN); 1H-NMR (DMSO-d6) δ (ppm): 2.47 (s, 3H, CH3-S), 7.67-
8.30 (m, 10H, Ar-H), 8.56 (s, 1H, C5-H pyridine); MS (EI, 70 eV): m/z (%) = 302 (M+, 100). Anal. Calcd. for 
C19H14N2S (302.39): C, 75.47; H, 4.67; N, 9.26%. Found: C, 75.41; H, 4.62; N, 9.20%. 
4.3. Synthesis of 3-amino-4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine (5) 
A mixture of 3 (1 mmol) and hydrazine hydrate (1 mmol) was refluxed for 6h. The product separated after partial 
evaporation of the solution was collected by filtration and crystallized from ethanol. Yield (90%); white powder; 
m.p. 165 oC; IR (KBr): ν/cm-1= 3350 (NH2), 3225 (NH); 1H-NMR (DMSO-d6) δ (ppm): 6.51 (s, 2H, NH2), 7.46-
8.30 (m, 10H, Ar-H), 7.84 (s, 1H, C5-H pyridine), 12.80 (s,1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 155.0, 
154.0, 150.0, 132.0, 137.0-127.0 (aromatic carbons), 121.0, 91.5; MS (EI, 70 eV): m/z (%) = 288 (M++2, 15), 
287 (M++1, 30), 286 (M+, 100). Anal. Calcd. for C18H14N4 (286.33): C, 75.50; H, 4.93; N, 19.57%. Found: C, 
75.46; H, 4.88; N, 19.50%. 
4.4. General procedure for the synthesis of 2-(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl-isoindolin-1,3-
dione derivatives 6-11 
A mixture of compound 5 (1 mmol) and anhydride derivatives namely; phthalic anhydride (1 mmol), 4-
nitrophthalic anhydride (1 mmol), 3-nitro-phthalic anhydride (1 mmol), 3,4,5,6-tetrabromophthalic anhydride (1 
mmol), 1,2,4-benzenetricarboxylic anhydride (trimellitic anhydride) (1 mmol), and/ or 1,2,4,5-
benzenetetracarboxylic dianhydride (0.5 mmol) in ethanol (15 ml) containing glacial acetic acid (5 drops) was 
refluxed for 2h. The reaction mixture was left to cool at room temperature; the precipitated solid product was 
filtered off, dried and recrystallized from ethanol to give compounds 6-11, respectively. 
4.4.1. 2-(4,6-Diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)isoindolin-1,3-dione (6) 
Yield (90%); pale yellow powder; m.p.> 300 oC; IR (KBr): ν/cm-1= 3250 (NH), 1695 (C=O, imide), 1620 (C=N), 
1579 (C=C); 1H-NMR (DMSO-d6) δ (ppm): 7.81 (s, 1H, C5-H pyridine), 7.35-8.10 (m, 14H, Ar-H), 12.10 (s,1H, 
NH); 13C-NMR (DMSO-d6) δ (ppm): 167.1 (C=O); 155.0, 154.0, 150.0, 131.0, 127.0-136.0 (aromatic carbons), 
122.0, 91.5; MS (EI, 70 eV): m/z (%) = 417 (M++1, 28), 416 (M+, 100), 415 (M+-1, 12), 372 (27.5), 296 (30.1), 
270 (15). Anal. Calcd. for C26H16N4O2 (416.43): C, 74.99; H, 3.87; N, 13.45%. Found: C, 74.91; H, 3.80; N, 
13.39%. 
4.4.2. 2-(4,6-Diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)-5-nitroisoindolin-1,3-dione (7) 
Yield (80%); white powder; m.p.> 300 oC; IR (KBr): ν/cm-1= 3235 (NH), 1684 (C=O), 1625 (C=N), 1580 (C=C), 
1530,1350 (NO2); 1H-NMR (DMSO-d6) δ (ppm): 7.62 (s, 1H, Ar-H), 7.40-8.10 (m,10H, Ar-H), 7.71 (d, 1H, Ar-
H), 7.80 (s, 1H, C5-H pyridine), 7.82 (d, 1H, Ar-H), 12.1 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 173.0, 
167.0, 155.0, 154.0, 150.0, 146.0 (C-NO2), 131.0, 127.0-137.0 (aromatic carbons), 121.0, 91.0; MS (EI, 70 eV): 
m/z (%) = 462 (M++1, 28), 461 (M+, 100), 417 (30), 295 (28), 269 (13), 118 (12), 102 (8). Anal. Calcd. for 
C26H15N5O4 (461.43): C, 67.68; H, 3.28; N, 15.18%. Found: C, 67.61; H, 3.76; N, 15.01%. 
4.4.3. 2-(4,6-Diphenyl-2H-pyrazolo[3,4-b]pyridine-3yl)-4-nitroisoindolin-1,3-dione (8) 
Yield (89%); pale yellow powder; m.p.185 oC; IR (KBr): ν/cm-1= 3189 (NH), 1680 (C=O), 1625 (C=N), 1575 
(C=C), 1535,1345 (NO2); MS (EI, 70 eV): m/z (%) = 462 (M++1, 18), 461 (M+, 100), 417 (25), 296 (30), 269 
(20), 118 (15), 102 (12). Anal. Calcd. for C26H15N5O4 (461.43): C, 67.68; H, 3.28; N, 15.18%. Found: C, 67.65; 
H, 3.22; N, 15.17%. 
4.4.4. 2-(4,6-Diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)-4,5,6,7-tetrabromo-isoindolin-1,3-dione (9) 
Yield (91%); pale yellow powder; m.p.> 300 oC; IR (KBr): ν/cm-1= 3230 (NH), 1704 (C=O); 13C-NMR (DMSO-
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d6) δ (ppm): 173.0, 167.0, 155.0, 154.0, 151.0, 130.0, 126.0-135 (aromatic carbons), 121.0, 91.0; MS (EI, 70 eV): 
m/z (%) = 733 (M++2, 62.3), 731 (M+, 100), 729 (66.5), 687 (35), 435 (41), 296 (30), 270 (15). Anal. Calcd. for 
C26H12Br4N4O2 (732.02): C, 42.66; H, 1.65; N, 7.65%. Found: C, 42.62; H, 1.61; N, 7.60%. 
4.4.5. 2-(4,6-Diphenyl-2H-pyrazolo[3,4-b]pyridin-3-yl)isoindolin-1,3-dione-5-carboxylic acid (10) 
Yield (85%); yellow powder; m.p.> 300 oC; IR (KBr): ν/cm-1= 3355 (NH), 1739 (C=O), 1700 (C=O), 1620 
(C=N); 1H-NMR (DMSO-d6) δ (ppm): 7.40-8.30 (m, 10H, Ar-H), 7.65 (s, 1H, Ar-H), 7.70 (d, 1H, Ar-H), 7.76 (s, 
1H, C5-H pyridine), 7.82 (d,1H, Ar-H), 12.21 (s, 1H, NH), 13.10 (s, 1H, COOH); 13C-NMR (DMSO-d6) δ (ppm): 
173.0, 170 (COOH), 167.0, 155.0, 154.0, 151.0, 130.0, 126.0-135.0 (aromatic carbons), 121.0, 90.0; MS (EI, 70 
eV): m/z (%) = 461 (M++1, 30), 460 (M+, 100), 416 (35), 296 (38), 270 (40), 165 (12), 121 (31). Anal. Calcd. for 
C27H16N4O4 (460.44): C, 70.43; H, 3.50; N, 12.17%. Found: C, 70.38; H, 3.47; N, 12.10%. 
 
4.4.6.2,6-bis(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridin-3-yl)pyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone (11) 
Yield (91%); pale yellow powder; m.p.> 330 oC; IR (KBr): ν/cm-1= 3380 (NH), 1689 (C=O); MS (EI, 70 eV): 
m/z (%) = 756 (M++2, 14), 755 (M++1, 50), 754 (M+, 100), 710 (30), 666 (55), 414 (60), 370 (30), 296 (15), 270 
(22), 118 (20), 102 (10), 74 (11). Anal. Calcd. for C46H26N8O4 (754.75): C, 73.20; H, 3.47; N, 14.85%. Found: C, 
73.10; H, 3.37; N, 14.80%. 
4.5. Synthesis of 3-(4,6-diphenyl-2H-pyrazolo[3,4-b]pyridine-3-yl)-quinazoline-2,4-(1H,3H)-dione (12) 
A mixture of compound 5 (1 mmol) and isatoic anhydride (1 mmol) in ethanol (50 ml) containing few drops of 
glacial acetic acid was stirred for 3h. at room temperature. The resulting crystals were filtered off, dried, and 
recrystallized from ethanol to give compound 12. Yield (80%); yellowish crystals; m.p 240 oC; IR (KBr): ν/cm-
1
= 3330, 3250 (2NH), 1677 (C=O), 1620 (C=N); 1H-NMR (DMSO-d6) δ (ppm): 7.40-8.30 (m,14H, Ar-H), 7.79 
(s, 1H, C5-H pyridine), 12.30 (s, 1H, NH), 12.76 (s, 1H, NH); 13C-NMR (DMSO-d6) δ (ppm): 158.0, 155.0, 
154.0, 150.0, 132.0, 127.0-137.0 (aromatic carbons), 121.0, 91.5; MS (EI, 70 eV): m/z (%) = 432 (M++1, 28), 
431 (M+, 100), 387 (30), 336 (28), 286 (13), 118 (12), 102 (8). Anal. Calcd. for C26H17N5O2 (431.45): C, 72.38; 
H, 3.97; N, 16.23%. Found: C, 72.28; H, 3.90; N, 16.10%. 
4.6. Cytotoxicity Activity 
RPMI-1640 medium (Sigma Co., St. Louis, USA), Foetal Bovine serum (GIBCO, UK), and the cell lines from 
ATCC were used. 
The cytotoxic activity of the synthesized compounds was targeted against human heptacellular liver carcinoma 
cell line (HepG2), human lung fibroblast cell line (WI-38), human causcasian breast adenocarcinoma cell line 
(MCF-7), and normal adult African green monkey kidney cell line (VERO). The stock samples of the 
compounds were diluted with RPMI-1640 medium to desired concentrations ranging from 10 to 1000 µg/mL. 
The final concentration of DMSO in each sample did not exceed 1% v/v. 
The cells were bath-cultured for 10 d, then seeded in 96 well plates of 10x103 cells/well in fresh complete 
growth medium in 96-well microtiter plastic plates at 37 °C for 24 h. under 5% CO2 using a water jacketed 
carbon dioxide incubator (Shedon. TC2323. Cornelius, OR, USA). The medium (without serum) was added and 
cells were incubated either alone (negative control) or with different concentrations of sample to give a final 
concentrations of (1000, 500, 200, 100, 50, 20, 10 µg/mL). Cells were suspended in RPMI-1640 medium, 1% 
antibiotic-antimycotic mixture (104 u/mL) potassium penicillin, 104 µg/mL streptomycin sulfate and 25 µg/mL A 
mphotericin B) and 1% L-glutamin in 96-well flat bottom microplates at 37 °C under 5% CO2. After 96 h. of 
incubation, the medium was again aspirated, trays were inverted onto a pad of paper towels, the remaining cells 
rinsed carefully with medium, and fixed with 3.7% (v/v) formaldehyde in saline for at least 20 min. The fixed 
cells were rinsed with water. The %viability of cells was examined visually as described previously [28]. 
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